(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

dalfopristin
type: Concept
broader: tertiary amino compound

alpha-putrescinylthymine
type: Concept
broader: tertiary amino compound

Perzinfotel
type: Concept
broader: tertiary amino compound

cyverine
type: Concept
broader: tertiary amino compound

19-O-acetylhoerhammericine
type: Concept
broader: tertiary amino compound

N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
type: Concept
broader: tertiary amino compound

2-[[4-(3-methylanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol
type: Concept
broader: tertiary amino compound

alcaftadine
type: Concept
broader: tertiary amino compound

ajaconine
type: Concept
broader: tertiary amino compound

3_STAR
type: ConceptGroup
member: tertiary amino compound

2-chloro-N,N-dipropylquinazolin-4-amine
type: Concept
broader: tertiary amino compound

(-)-echitovenine
type: Concept
broader: tertiary amino compound

clorgyline
type: Concept
broader: tertiary amino compound

6-(dimethylamino)-cPuMP
type: Concept
broader: tertiary amino compound

4-diphenylacetoxy-N-methylpiperidine
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

PJ34
type: Concept
broader: tertiary amino compound

1-[[4-(dimethylamino)phenyl]methylideneamino]-3-(2-furanylmethyl)thiourea
type: Concept
broader: tertiary amino compound

lucidine B
type: Concept
broader: tertiary amino compound

Methyl violet 2B free base
type: Concept
broader: tertiary amino compound

belladine
type: Concept
broader: tertiary amino compound

azaperone
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

5-(3-cyclohexyl-1-pyrrolidinyl)-6-phenyl-3-(2-pyridinyl)-1,2,4-triazine
type: Concept
broader: tertiary amino compound

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

nile red
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

N4-ethyl-N6,1,2-trimethyl-N4-phenylpyrimidin-1-ium-4,6-diamine
type: Concept
broader: tertiary amino compound

MMP9 inhibitor I
type: Concept
broader: tertiary amino compound

LY-310762
type: Concept
broader: tertiary amino compound

LY-367,265
type: Concept
broader: tertiary amino compound

N(2)-[3-methoxy-4-(morpholin-4-yl)phenyl]-N(4)-(quinolin-3-yl)pyrimidine-2,4-diamine
type: Concept
broader: tertiary amino compound

9-ethyl-3-carbazolecarboxaldehyde oxime
type: Concept
broader: tertiary amino compound

tenocyclidine
type: Concept
broader: tertiary amino compound

4-(4-bromophenyl)-2-[4-(2H-tetrazol-5-yl)-1-piperidinyl]thiazole
type: Concept
broader: tertiary amino compound

oryzalin
type: Concept
broader: tertiary amino compound

2-{[(2E)-3-iodoprop-2-en-1-yl](propyl)amino}tetralin-7-ol
type: Concept
broader: tertiary amino compound

mesoridazine
type: Concept
broader: tertiary amino compound

3-(4-ethyl-1-piperazinyl)-5-methylpyridazino[3,4-b][1,4]benzoxazine
type: Concept
broader: tertiary amino compound

LSM-11916
type: Concept
broader: tertiary amino compound

2-Ethyl-N-(2-ethylhexyl)-N-methyl-1-hexanamine
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline
type: Concept
broader: tertiary amino compound

2-(4-Dimethylaminophenyl)-3-(2-pyridyl)thiazolidin-4-one
type: Concept
broader: tertiary amino compound

cinchocaine
type: Concept
broader: tertiary amino compound

N-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
type: Concept
broader: tertiary amino compound

3,7-bis(dimethylamino)phenothiazine
type: Concept
broader: tertiary amino compound

4-(diethylamino)but-2-yn-1-ol
type: Concept
broader: tertiary amino compound

2-diethylaminoethanol
type: Concept
broader: tertiary amino compound

5-hydroxyvomicine
type: Concept
broader: tertiary amino compound

piromidic acid
type: Concept
broader: tertiary amino compound

lissoclibadin 3
type: Concept
broader: tertiary amino compound

5-(dimethylamino)-N-(4-aminobenzyl)naphthalene-1-sulfonamide
type: Concept
broader: tertiary amino compound

N,N-dimethyl-4-nitrosoaniline
type: Concept
broader: tertiary amino compound

benzoylmesaconine
type: Concept
broader: tertiary amino compound

nothramicin
type: Concept
broader: tertiary amino compound

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
type: Concept
broader: tertiary amino compound

N-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
type: Concept
broader: tertiary amino compound

lissoclibadin 2
type: Concept
broader: tertiary amino compound

scopolamine
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

miglustat
type: Concept
broader: tertiary amino compound

abamine
type: Concept
broader: tertiary amino compound

4-chloro-5-(dimethylamino)-2-(4-methylphenyl)-3-pyridazinone
type: Concept
broader: tertiary amino compound

N-(1-benzylpiperidin-4-yl)-2-(pyridin-3-yl)quinazolin-4-amine
type: Concept
broader: tertiary amino compound

N-methylpiperazine
type: Concept
broader: tertiary amino compound

2-[[2-oxo-2-[4-[5-(trifluoromethyl)-2-pyridinyl]-1,4-diazepan-1-yl]ethyl]thio]acetic acid
type: Concept
broader: tertiary amino compound

5-(2-chloro-6-fluorobenzyl)-6-methyl-2-morpholinopyrimidin-4-ol
type: Concept
broader: tertiary amino compound

8-{1-[4-(dimethylamino)phenyl]-3-(pyrrolidin-1-yl)propyl}-5,7-dimethoxy-4-pentyl-2H-chromen-2-one
type: Concept
broader: tertiary amino compound

N-(1-benzylpyrrolidin-3-yl)-5,6-dimethylthieno[2,3-d]pyrimidin-4-amine
type: Concept
broader: tertiary amino compound

N-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

onetine
type: Concept
broader: tertiary amino compound

(+)-minovincinine
type: Concept
broader: tertiary amino compound

cinaciguat
type: Concept
broader: tertiary amino compound

triethylenediamine
type: Concept
broader: tertiary amino compound

N-methylproline
type: Concept
broader: tertiary amino compound

hypaconine
type: Concept
broader: tertiary amino compound

1-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea
type: Concept
broader: tertiary amino compound

triethanolamine
type: Concept
broader: tertiary amino compound

1-[3-[(5-bromo-2-pyridinyl)-butylamino]propyl]-3-[3-(1H-imidazol-5-yl)propyl]thiourea
type: Concept
broader: tertiary amino compound

1-(1-methylpyrrolidin-2-yl)acetone
type: Concept
broader: tertiary amino compound

1-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

1-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

AF-DX 384
type: Concept
broader: tertiary amino compound

chlorambucil
type: Concept
broader: tertiary amino compound

isostrychnine
type: Concept
broader: tertiary amino compound

7-(1-azepanyl)-2-oxoheptanal oxime
type: Concept
broader: tertiary amino compound

taxine B
type: Concept
broader: tertiary amino compound

2,6-dimethyl-4-undecylmorpholine
type: Concept
broader: tertiary amino compound

psilocin
type: Concept
broader: tertiary amino compound

TOP-53
type: Concept
broader: tertiary amino compound

dauricine
type: Concept
broader: tertiary amino compound

2,6-dimethyl-4-tetradecylmorpholine
type: Concept
broader: tertiary amino compound

venlafaxine
type: Concept
broader: tertiary amino compound

3-O-acetyl-4'-O-demethylpapaveroxine
type: Concept
broader: tertiary amino compound

tubastatin A
type: Concept
broader: tertiary amino compound

conessine
type: Concept
broader: tertiary amino compound

10-deoxysarpagine
type: Concept
broader: tertiary amino compound

antazoline
type: Concept
broader: tertiary amino compound

17-O-acetylnorajmaline
type: Concept
broader: tertiary amino compound

tabernaemontanine
type: Concept
broader: tertiary amino compound

Isothipendyl hydrochloride
type: Concept
broader: tertiary amino compound

N-[[(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

acridine orange free base
type: Concept
broader: tertiary amino compound

lofentanyl
type: Concept
broader: tertiary amino compound

SU11652
type: Concept
broader: tertiary amino compound

bromhexine
type: Concept
broader: tertiary amino compound

palbociclib
type: Concept
broader: tertiary amino compound

amiodarone
type: Concept
broader: tertiary amino compound

hydroxyethylflurazepam
type: Concept
broader: tertiary amino compound

ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate
type: Concept
broader: tertiary amino compound

chlorprothixene
type: Concept
broader: tertiary amino compound

trabectedin
type: Concept
broader: tertiary amino compound

N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
type: Concept
broader: tertiary amino compound

3-methyl-4'-dimethylaminoazobenzene
type: Concept
broader: tertiary amino compound

citrinalin B
type: Concept
broader: tertiary amino compound

8-Hydroxynevirapine
type: Concept
broader: tertiary amino compound

N-(2,6-dichlorobenzyl)-3-[2-(2,6-dichlorophenyl)-6-quinolyl]-N-methylalanine
type: Concept
broader: tertiary amino compound

1-[[(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea
type: Concept
broader: tertiary amino compound

4-{bis[4-(dimethylamino)phenyl]methyl}phenol
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

oxolucidine B
type: Concept
broader: tertiary amino compound

4-azaleucine
type: Concept
broader: tertiary amino compound

3-[(dimethylamino)methyl]-5-[(4-methoxyphenyl)methylidene]-1,3-thiazolidine-2,4-dione
type: Concept
broader: tertiary amino compound

reversine
type: Concept
broader: tertiary amino compound

3-(1-pyrrolidinyl)-5-(trifluoromethyl)pyridine-2-carbothioamide
type: Concept
broader: tertiary amino compound

2-[[4-(2-chloroanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol
type: Concept
broader: tertiary amino compound

1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine
type: Concept
broader: tertiary amino compound

deltaline
type: Concept
broader: tertiary amino compound

AZD-1152
type: Concept
broader: tertiary amino compound

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

sarpagine
type: Concept
broader: tertiary amino compound

4-dodecyl-2,5-dimethylmorpholine
type: Concept
broader: tertiary amino compound

benzoylaconine
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

5-(1-azepanyl)-1,3,4-thiadiazol-2-amine
type: Concept
broader: tertiary amino compound

Thenyldiamine
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
type: Concept
broader: tertiary amino compound

N(4)-aminopropylspermidine
type: Concept
broader: tertiary amino compound

protostrychnine
type: Concept
broader: tertiary amino compound

quinacrine
type: Concept
broader: tertiary amino compound

N,N-Dimethyl-3-phenyl-3-pyridin-2-ylpropan-1-amine oxide
type: Concept
broader: tertiary amino compound

ethylene glycol bis(2-aminoethyl)tetraacetic acid
type: Concept
broader: tertiary amino compound

afatinib
type: Concept
broader: tertiary amino compound

erucifoline
type: Concept
broader: tertiary amino compound

LSM-11217
type: Concept
broader: tertiary amino compound

PA-16-0081C
type: Concept
broader: tertiary amino compound

N-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

jaconine
type: Concept
broader: tertiary amino compound

PX-866
type: Concept
broader: tertiary amino compound

N-ethyl-1-deoxynojirimycin
type: Concept
broader: tertiary amino compound

PDGF receptor tyrosine kinase inhibitor III
type: Concept
broader: tertiary amino compound

Emicerfont
type: Concept
broader: tertiary amino compound

N-alkylpiperazine
type: Concept
broader: tertiary amino compound

promazine sulfoxide
type: Concept
broader: tertiary amino compound

1-(3,6-dibromocarbazol-9-yl)-3-(dimethylamino)propan-2-ol
type: Concept
broader: tertiary amino compound

ankorine
type: Concept
broader: tertiary amino compound

SCH 23390
type: Concept
broader: tertiary amino compound

(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
type: Concept
broader: tertiary amino compound

ketotifen
type: Concept
broader: tertiary amino compound

chloropyrilene
type: Concept
broader: tertiary amino compound

N(4)-aminopropylspermine
type: Concept
broader: tertiary amino compound

dregamine
type: Concept
broader: tertiary amino compound

N-Methyldioctylamine
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

leucomethylene blue
type: Concept
broader: tertiary amino compound

5-chloro-N4-(cyclopropylmethyl)-2-methyl-N4-propyl-N6-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine
type: Concept
broader: tertiary amino compound

2-amino-4-(cyanomethyl)-6-(N-methylanilino)pyridine-3,5-dicarbonitrile
type: Concept
broader: tertiary amino compound

2-chloro-N-[4-(N-propan-2-ylanilino)phenyl]acetamide
type: Concept
broader: tertiary amino compound

tiagabine
type: Concept
broader: tertiary amino compound

nafadotride
type: Concept
broader: tertiary amino compound

gefitinib
type: Concept
broader: tertiary amino compound

cassaine
type: Concept
broader: tertiary amino compound

Ro 25-6981
type: Concept
broader: tertiary amino compound

1-[[(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

AZD3463
type: Concept
broader: tertiary amino compound

Diethatyl-ethyl
type: Concept
broader: tertiary amino compound

N2,N4-bis[[4-(dimethylamino)phenyl]methylideneamino]-3,5-dimethyl-1H-pyrrole-2,4-dicarboxamide
type: Concept
broader: tertiary amino compound

biperiden
type: Concept
broader: tertiary amino compound

isopseudostrychnine
type: Concept
broader: tertiary amino compound

(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
type: Concept
broader: tertiary amino compound

(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

ranitidine-S-oxide
type: Concept
broader: tertiary amino compound

N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

1-[[(2R,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

lofepramine
type: Concept
broader: tertiary amino compound

isobrucine
type: Concept
broader: tertiary amino compound

1-(4-chlorophenyl)-2-[5-(1-pyrrolidinyl)-2-tetrazolyl]ethanone oxime
type: Concept
broader: tertiary amino compound

veracevine
type: Concept
broader: tertiary amino compound

metoclopramide
type: Concept
broader: tertiary amino compound

2-(4-Dimethylaminophenyl)-3-(6-methyl-2-pyridyl)thiazolidin-4-one
type: Concept
broader: tertiary amino compound

ibogamine
type: Concept
broader: tertiary amino compound

(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

(R)-laudanosine
type: Concept
broader: tertiary amino compound

1-[[(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

pildralazine
type: Concept
broader: tertiary amino compound

1-[[(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

spiramide
type: Concept
broader: tertiary amino compound

4-[methyl-(4-thiophen-2-yl-2-thiazolyl)amino]phenol
type: Concept
broader: tertiary amino compound

1-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea
type: Concept
broader: tertiary amino compound

hokbusine A
type: Concept
broader: tertiary amino compound

dronedarone
type: Concept
broader: tertiary amino compound

icaceine
type: Concept
broader: tertiary amino compound

N,N-dimethyl-4-[[6-(3-pyridinyl)-3,4-dihydro-2H-pyridin-5-ylidene]methyl]aniline
type: Concept
broader: tertiary amino compound

2-(morpholin-4-yl)ethanol
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methylmethanesulfonamide
type: Concept
broader: tertiary amino compound

(4aR,10bS)-noroxomaritidine
type: Concept
broader: tertiary amino compound

alangimarckine
type: Concept
broader: tertiary amino compound

methyl N-(2,6-dichlorobenzyl)-3-[2-(2,6-dichlorophenyl)-6-quinolyl]-N-methylalaninate
type: Concept
broader: tertiary amino compound

delgocitinib
type: Concept
broader: tertiary amino compound

(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

carmoxirole
type: Concept
broader: tertiary amino compound

guattegaumerine
type: Concept
broader: tertiary amino compound

rivastigmine
type: Concept
broader: tertiary amino compound

VX nerve agent
type: Concept
broader: tertiary amino compound

N-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

N-Ethyl-N-methyl-1,2-ethanediamine
type: Concept
broader: tertiary amino compound

xaliproden
type: Concept
broader: tertiary amino compound

1-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
type: Concept
broader: tertiary amino compound

amitraz
type: Concept
broader: tertiary amino compound

1-[9-ethyl-6-(1-hydroxyiminoethyl)-3-carbazolyl]ethanone oxime
type: Concept
broader: tertiary amino compound

bedaquiline
type: Concept
broader: tertiary amino compound

N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide
type: Concept
broader: tertiary amino compound

acetylerucifoline
type: Concept
broader: tertiary amino compound

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

pseudopelletierine
type: Concept
broader: tertiary amino compound

jacozine
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

navitoclax
type: Concept
broader: tertiary amino compound

1-(4-methoxyphenyl)-N-methyl-N-[(3-methyloxetan-3-yl)methyl]methanamine
type: Concept
broader: tertiary amino compound

1-(2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
type: Concept
broader: tertiary amino compound

vindesine
type: Concept
broader: tertiary amino compound

N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)-1-(N,N-dimethylglycyl)piperidine-4-carboxamide
type: Concept
broader: tertiary amino compound

bosutinib
type: Concept
broader: tertiary amino compound

(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

2-chloro-2'-hydroxytriethylamine
type: Concept
broader: tertiary amino compound

2,3,8,9-tetramethoxy-13-methyl-5,6,11,12-tetrahydro-5,11-epiminodibenzo[a,e][8]annulene
type: Concept
broader: tertiary amino compound

4-amino-5-chloro-2-ethoxy-N-({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)benzamide
type: Concept
broader: tertiary amino compound

5-(N-methyl-N-propyl)amiloride
type: Concept
broader: tertiary amino compound

5-{N-[4-(4-cyanostyryl)phenyl]-N-methylamino}pentanoic acid
type: Concept
broader: tertiary amino compound

2-Hydroxynevirapine
type: Concept
broader: tertiary amino compound

profenamine
type: Concept
broader: tertiary amino compound

dehydrojaconine
type: Concept
broader: tertiary amino compound

(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

rocuronium
type: Concept
broader: tertiary amino compound

N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
type: Concept
broader: tertiary amino compound

1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
type: Concept
broader: tertiary amino compound

2-[[4-(dimethylamino)phenyl]methylidene]-1-cyclohexanone
type: Concept
broader: tertiary amino compound

14-hydroxyicajine
type: Concept
broader: tertiary amino compound

dimethylphosphatidylethanolamine 32:0
type: Concept
broader: tertiary amino compound

bromazine
type: Concept
broader: tertiary amino compound

N-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

vindolinine
type: Concept
broader: tertiary amino compound

3beta-(2-diethylaminoethoxy)androst-5-en-17-one
type: Concept
broader: tertiary amino compound

NOC-5
type: Concept
broader: tertiary amino compound

isotalatizidine
type: Concept
broader: tertiary amino compound

4-[[4-bromo-5-(4-morpholinyl)-2-furanyl]methylideneamino]phenol
type: Concept
broader: tertiary amino compound

SU4312
type: Concept
broader: tertiary amino compound

(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
type: Concept
broader: tertiary amino compound

ZM447439
type: Concept
broader: tertiary amino compound

(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methylmethanesulfonamide
type: Concept
broader: tertiary amino compound

2-cyano-3-[5-(dimethylamino)-2-furanyl]-N-(phenylmethyl)-2-propenamide
type: Concept
broader: tertiary amino compound

noribogaine
type: Concept
broader: tertiary amino compound

tubulosine
type: Concept
broader: tertiary amino compound

deoxyaconitine
type: Concept
broader: tertiary amino compound

N-[[(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

2-[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)anilino]-5,11-dimethyl-6-pyrimido[4,5-b][1,4]benzodiazepinone
type: Concept
broader: tertiary amino compound

oxybutynin
type: Concept
broader: tertiary amino compound

4-dodecyl-2,6-dimethylmorpholine
type: Concept
broader: tertiary amino compound

dimantine
type: Concept
broader: tertiary amino compound

tertiary amine
type: Concept
broader: tertiary amino compound

stryvomitine
type: Concept
broader: tertiary amino compound

4-(2,3-dihydro-1H-indol-1-yl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine
type: Concept
broader: tertiary amino compound

(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

N-(3-chloro-4-fluorophenyl)-6-[4-(diethylaminomethyl)-1-piperidinyl]-4-pyrimido[5,4-d]pyrimidinamine
type: Concept
broader: tertiary amino compound

N,N-bis(2-methoxyethyl)-2-(4-methylphenyl)quinazolin-4-amine
type: Concept
broader: tertiary amino compound

2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol
type: Concept
broader: tertiary amino compound

2-(dimethylamino)-cAMP
type: Concept
broader: tertiary amino compound

florosenine
type: Concept
broader: tertiary amino compound

7-(2-methyl-2,3-dihydroindol-1-yl)-3-(phenylmethyl)triazolo[4,5-d]pyrimidine
type: Concept
broader: tertiary amino compound

galanthamine
type: Concept
broader: tertiary amino compound

1-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

yunaconitine
type: Concept
broader: tertiary amino compound

11-hydroxyicajine
type: Concept
broader: tertiary amino compound

amorolfine
type: Concept
broader: tertiary amino compound

2-methyl-3-(pyrrolidin-1-yl)-1-[4-(trifluoromethyl)phenyl]propan-1-one
type: Concept
broader: tertiary amino compound

N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol
type: Concept
broader: tertiary amino compound

dasatinib (anhydrous)
type: Concept
broader: tertiary amino compound

(S)-codamine
type: Concept
broader: tertiary amino compound

glyphosine
type: Concept
broader: tertiary amino compound

N-methyl-1-deoxynojirimycin
type: Concept
broader: tertiary amino compound

1-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea
type: Concept
broader: tertiary amino compound

1-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

azelastine
type: Concept
broader: tertiary amino compound

ACT-333679
type: Concept
broader: tertiary amino compound

1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane
type: Concept
broader: tertiary amino compound

N-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
type: Concept
broader: tertiary amino compound

karakoline
type: Concept
broader: tertiary amino compound

(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
type: Concept
broader: tertiary amino compound

4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
type: Concept
broader: tertiary amino compound

gramine
type: Concept
broader: tertiary amino compound

catharanthine
type: Concept
broader: tertiary amino compound

tiamulin
type: Concept
broader: tertiary amino compound

beta-erythroidine
type: Concept
broader: tertiary amino compound

LSM-12226
type: Concept
broader: tertiary amino compound

ecgonone methyl ester
type: Concept
broader: tertiary amino compound

spiperone
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
type: Concept
broader: tertiary amino compound

pipamperone
type: Concept
broader: tertiary amino compound

alvespimycin
type: Concept
broader: tertiary amino compound

antalarmin
type: Concept
broader: tertiary amino compound

2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

efinaconazole
type: Concept
broader: tertiary amino compound

dodemorph
type: Concept
broader: tertiary amino compound

clopidogrel carboxylic acid
type: Concept
broader: tertiary amino compound

N'-(3-chlorophenyl)-N,N-dimethyl-N'-phenylpropane-1,3-diamine
type: Concept
broader: tertiary amino compound

N-[[(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

4-Dimethylaminopyridine
type: Concept
broader: tertiary amino compound

7-hydroxyticlopidine
type: Concept
broader: tertiary amino compound

barbinine
type: Concept
broader: tertiary amino compound

isothipendyl
type: Concept
broader: tertiary amino compound

(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

LSM-12795
type: Concept
broader: tertiary amino compound

cephalotaxine
type: Concept
broader: tertiary amino compound

ulipristal acetate
type: Concept
broader: tertiary amino compound

(3R)-3-hydroxy-2,3-dihydrotabersonine
type: Concept
broader: tertiary amino compound

(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
type: Concept
broader: tertiary amino compound

3-(5-chloro-2-methylphenyl)-6-(2,6-dimethyl-4-morpholinyl)-1H-pyrimidine-2,4-dione
type: Concept
broader: tertiary amino compound

vincaleukoblastine
type: Concept
broader: tertiary amino compound

spiramycin II
type: Concept
broader: tertiary amino compound

secodine
type: Concept
broader: tertiary amino compound

flupyradifurone
type: Concept
broader: tertiary amino compound

mifepristone
type: Concept
broader: tertiary amino compound

triflusulfuron
type: Concept
broader: tertiary amino compound

N-[[(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
type: Concept
broader: tertiary amino compound

hydroxychloroquine
type: Concept
broader: tertiary amino compound

L-778,123 (free base)
type: Concept
broader: tertiary amino compound

foresticine
type: Concept
broader: tertiary amino compound

ICR 340 (free base)
type: Concept
broader: tertiary amino compound

NSC 23766
type: Concept
broader: tertiary amino compound

N-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
type: Concept
broader: tertiary amino compound

crassicauline A
type: Concept
broader: tertiary amino compound

vincristine
type: Concept
broader: tertiary amino compound

3-[4-(dimethylamino)phenyl]-N-methyl-5-(4-methylphenyl)-3,4-dihydropyrazole-2-carbothioamide
type: Concept
broader: tertiary amino compound

carfentanil
type: Concept
broader: tertiary amino compound

LSM-6299
type: Concept
broader: tertiary amino compound

20-oxo-5-O-beta-mycaminosyltylactone
type: Concept
broader: tertiary amino compound

Elaiomycin D
type: Concept
broader: tertiary amino compound

LSM-11987
type: Concept
broader: tertiary amino compound

otosenine
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
type: Concept
broader: tertiary amino compound

N-cyclopropyl-4-[4-(3,4-dichlorophenyl)-2-(1-methylpiperidin-4-yl)-1-propylimidazol-5-yl]pyrimidin-2-amine
type: Concept
broader: tertiary amino compound

VR nerve agent
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
type: Concept
broader: tertiary amino compound

1-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
type: Concept
broader: tertiary amino compound

phentolamine
type: Concept
broader: tertiary amino compound

N-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
type: Concept
broader: tertiary amino compound

(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

prothipendyl
type: Concept
broader: tertiary amino compound

N,N-dimethylformamide dimethyl acetal
type: Concept
broader: tertiary amino compound

HA15
type: Concept
broader: tertiary amino compound

2-[5-(4-chlorophenyl)-1,3,5-dithiazinan-2-ylidene]-2-diethoxyphosphorylacetonitrile
type: Concept
broader: tertiary amino compound

N,N-dimethyl-beta-alanine
type: Concept
broader: tertiary amino compound

tertiary amino compound
type: Concept
narrower: 4-(diethylamino)but-2-yn-1-ol
narrower: 2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI
narrower: 2-chloro-N,N-dipropylquinazolin-4-amine
narrower: dehydrojacoline
narrower: 2-[5-(4-chlorophenyl)-1,3,5-dithiazinan-2-ylidene]-2-diethoxyphosphorylacetonitrile
narrower: caracurine VII
narrower: devapamil
narrower: caulophine
narrower: auricin
narrower: tiamulin
narrower: 9-ethyl-3-carbazolecarboxaldehyde oxime
narrower: N-methyl-1-deoxynojirimycin
narrower: 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile
narrower: 3-cyclohexyl-1-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
narrower: mifepristone
narrower: 1-(4-chlorophenyl)-2-[4-(4-fluorobenzyl)piperidin-1-yl]ethanol
narrower: N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
narrower: tofacitinib
narrower: 1-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
narrower: N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
narrower: 2,6-diamino-1-{[(3S,4R,5R,6R)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy}-4-(piperidin-1-yl)pyrimidin-1-ium
narrower: 2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline
narrower: 1-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea
narrower: bosutinib
narrower: antalarmin
narrower: N-ethyldiethanolamine
narrower: CBL0137
narrower: rohitukine
narrower: lucidine B
narrower: AZT-1152
narrower: chloropyrilene
narrower: LSM-11217
narrower: morphine
narrower: VX nerve agent
narrower: (S)-glaucine
narrower: KFP-V47X1RDJ-D
narrower: stephanthrine
narrower: 2-(N-ethylanilino)-4-thieno[3,2-d][1,3]thiazinone
narrower: 2-chloro-N-[4-(N-propan-2-ylanilino)phenyl]acetamide
narrower: flupyradifurone
narrower: tabernaemontanine
narrower: jacoline
narrower: (+)-butaclamol
narrower: parbenate
narrower: KFP-HJMVJGFW-M
narrower: SCH772984
narrower: rocuronium
narrower: 6-(dimethylamino)-4,4-diphenylheptan-3-one
narrower: 1-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea
narrower: taxine B
narrower: triflusulfuron
narrower: N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
narrower: N,N-dimethyl-4-[[6-(3-pyridinyl)-3,4-dihydro-2H-pyridin-5-ylidene]methyl]aniline
narrower: icajine
narrower: sotorasib
narrower: 3-cyclohexyl-1-[[(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
narrower: granisetron
narrower: N2,N4-bis[[4-(dimethylamino)phenyl]methylideneamino]-3,5-dimethyl-1H-pyrrole-2,4-dicarboxamide
narrower: 1'-[3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]hexahydro-2H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-2-one
narrower: 1-[[(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
narrower: 4-(diethylamino)benzaldehyde
narrower: delgocitinib
narrower: 4-Dimethylaminopyridine
narrower: mesoridazine
narrower: mopidamol
narrower: abamine
narrower: neutral red base
narrower: 1-[4-(4-bromophenyl)-2-thiazolyl]-4-piperidinecarbonitrile
narrower: (2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
narrower: clorgyline
narrower: N-[[(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
narrower: 5-(N-methyl-N-propyl)amiloride
narrower: N-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
narrower: aconine
narrower: tropisetron
narrower: 3-cyclohexyl-1-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
narrower: 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine
narrower: 4-(4-bromophenyl)-2-[4-(2H-tetrazol-5-yl)-1-piperidinyl]thiazole
narrower: colforsin daropate

2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI
type: Concept
broader: tertiary amino compound

dehydrojacoline
type: Concept
broader: tertiary amino compound

caracurine VII
type: Concept
broader: tertiary amino compound

devapamil
type: Concept
broader: tertiary amino compound

caulophine
type: Concept
broader: tertiary amino compound

auricin
type: Concept
broader: tertiary amino compound

1-(4-chlorophenyl)-2-[4-(4-fluorobenzyl)piperidin-1-yl]ethanol
type: Concept
broader: tertiary amino compound

tofacitinib
type: Concept
broader: tertiary amino compound

N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
type: Concept
broader: tertiary amino compound

2,6-diamino-1-{[(3S,4R,5R,6R)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy}-4-(piperidin-1-yl)pyrimidin-1-ium
type: Concept
broader: tertiary amino compound

1-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea
type: Concept
broader: tertiary amino compound

N-ethyldiethanolamine
type: Concept
broader: tertiary amino compound

CBL0137
type: Concept
broader: tertiary amino compound

rohitukine
type: Concept
broader: tertiary amino compound

AZT-1152
type: Concept
broader: tertiary amino compound

morphine
type: Concept
broader: tertiary amino compound

(S)-glaucine
type: Concept
broader: tertiary amino compound

stephanthrine
type: Concept
broader: tertiary amino compound

2-(N-ethylanilino)-4-thieno[3,2-d][1,3]thiazinone
type: Concept
broader: tertiary amino compound

jacoline
type: Concept
broader: tertiary amino compound

(+)-butaclamol
type: Concept
broader: tertiary amino compound

parbenate
type: Concept
broader: tertiary amino compound

SCH772984
type: Concept
broader: tertiary amino compound

6-(dimethylamino)-4,4-diphenylheptan-3-one
type: Concept
broader: tertiary amino compound

icajine
type: Concept
broader: tertiary amino compound

sotorasib
type: Concept
broader: tertiary amino compound

granisetron
type: Concept
broader: tertiary amino compound

1'-[3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]hexahydro-2H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-2-one
type: Concept
broader: tertiary amino compound

4-(diethylamino)benzaldehyde
type: Concept
broader: tertiary amino compound

mopidamol
type: Concept
broader: tertiary amino compound

neutral red base
type: Concept
broader: tertiary amino compound

1-[4-(4-bromophenyl)-2-thiazolyl]-4-piperidinecarbonitrile
type: Concept
broader: tertiary amino compound

(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

aconine
type: Concept
broader: tertiary amino compound

tropisetron
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

colforsin daropate
type: Concept
broader: tertiary amino compound

amodiaquine
type: Concept
broader: tertiary amino compound

4-(5,6-diphenyl-1,2,4-triazin-3-yl)morpholine
type: Concept
broader: tertiary amino compound

dimethylphosphatidylethanolamine 34:1
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

1-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea
type: Concept
broader: tertiary amino compound

trovafloxacin
type: Concept
broader: tertiary amino compound

hookerianamide K
type: Concept
broader: tertiary amino compound

ecgonine methyl ester
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

propamocarb
type: Concept
broader: tertiary amino compound

pateamine
type: Concept
broader: tertiary amino compound

(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

neoline
type: Concept
broader: tertiary amino compound

1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine
type: Concept
broader: tertiary amino compound

1-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

GSK2879552
type: Concept
broader: tertiary amino compound

floridanine
type: Concept
broader: tertiary amino compound

5-[3-(dimethylamino)phenyl]-N-methyl-1,3,4-thiadiazol-2-amine
type: Concept
broader: tertiary amino compound

rac5c
type: Concept
broader: tertiary amino compound

lidocaine
type: Concept
broader: tertiary amino compound

nogalamycin
type: Concept
broader: tertiary amino compound

norajmaline
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

N-alkylpyrrolidine
type: Concept
broader: tertiary amino compound

5-[[4-(dimethylamino)phenyl]methylidene]-2-sulfanylidene-1,3-thiazinan-4-one
type: Concept
broader: tertiary amino compound

N-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
type: Concept
broader: tertiary amino compound

2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate
type: Concept
broader: tertiary amino compound

N-arylpiperazine
type: Concept
broader: tertiary amino compound

5-methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine
type: Concept
broader: tertiary amino compound

4-dimethylaminophenol
type: Concept
broader: tertiary amino compound

1-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

sporidesmin A
type: Concept
broader: tertiary amino compound

chasmanine
type: Concept
broader: tertiary amino compound

2-{[(4-methoxybenzyl)(methyl)amino]methyl}-2-methylpropane-1,3-diol
type: Concept
broader: tertiary amino compound

(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

N-methyl-2-(4-methylphenyl)-N-(1-methylpiperidin-4-yl)quinazolin-4-amine
type: Concept
broader: tertiary amino compound

N4-(2-furanylmethyl)-N2-(3-methylphenyl)-6-(4-morpholinyl)-1,3,5-triazine-2,4-diamine
type: Concept
broader: tertiary amino compound

N-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
type: Concept
broader: tertiary amino compound

(3R)-1,2-didehydro-3-hydroxy-16-methoxy-2,3-dihydrotabersonine
type: Concept
broader: tertiary amino compound

ABT-737
type: Concept
broader: tertiary amino compound

N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

2-(morpholin-4-yloxy)ethanol
type: Concept
broader: tertiary amino compound

AP20187
type: Concept
broader: tertiary amino compound

dithiadene
type: Concept
broader: tertiary amino compound

edoxaban
type: Concept
broader: tertiary amino compound

irinotecan
type: Concept
broader: tertiary amino compound

5-(dimethylamino)-N-[4-(hydroxyamino)benzyl]naphthalene-1-sulfonamide
type: Concept
broader: tertiary amino compound

LSM-9861
type: Concept
broader: tertiary amino compound

N-[[(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
type: Concept
broader: tertiary amino compound

LSM-8542
type: Concept
broader: tertiary amino compound

oxypendyl
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2R,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

1-(6-chloro-2-pyridinyl)-4-piperidinamine
type: Concept
broader: tertiary amino compound

neojiangyouaconitine
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate
type: Concept
broader: tertiary amino compound

pimavanserin
type: Concept
broader: tertiary amino compound

pracinostat
type: Concept
broader: tertiary amino compound

N-[3-(N-ethylanilino)propyl]-2,4-dimethyl-6-oxo-3-pyrancarboxamide
type: Concept
broader: tertiary amino compound

4-bromo-2-phenyl-5-(1-piperidinyl)-3-pyridazinone
type: Concept
broader: tertiary amino compound

procaine
type: Concept
broader: tertiary amino compound

N-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
type: Concept
broader: tertiary amino compound

(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
type: Concept
broader: tertiary amino compound

methyl red
type: Concept
broader: tertiary amino compound

chloroquine
type: Concept
broader: tertiary amino compound

AMG-925
type: Concept
broader: tertiary amino compound

AS1842856
type: Concept
broader: tertiary amino compound

plerixafor
type: Concept
broader: tertiary amino compound

hesperadin
type: Concept
broader: tertiary amino compound

N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine
type: Concept
broader: tertiary amino compound

Solvent yellow 56
type: Concept
broader: tertiary amino compound

isoretuline
type: Concept
broader: tertiary amino compound

2-(piperidin-1-yl)ethanol
type: Concept
broader: tertiary amino compound

foresaconitine
type: Concept
broader: tertiary amino compound

2-(2,3-dihydro-1,4-benzoxazin-4-yl)-8-methoxy-N-(phenylmethyl)-4-quinazolinamine
type: Concept
broader: tertiary amino compound

setiptiline
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

doxepin
type: Concept
broader: tertiary amino compound

N-[[(2R,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methylmethanesulfonamide
type: Concept
broader: tertiary amino compound

(R)-8-[(dimethylamino)methyl]-1-[3-(dimethylamino)propyl]-1,7,8,9-tetrahydrochromeno[5,6-d]imidazol-2-amine
type: Concept
broader: tertiary amino compound

cycrimine
type: Concept
broader: tertiary amino compound

dimethylphosphatidylethanolamine 36:3
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

finafloxacin
type: Concept
broader: tertiary amino compound

2-(2,4-dioxo-1H-pyrimidin-6-yl)-N-[2-(4-morpholinyl)ethyl]acetamide
type: Concept
broader: tertiary amino compound

1,1-diethyl-2-hydroxy-3-oxotriazane
type: Concept
broader: tertiary amino compound

orphenadrine
type: Concept
broader: tertiary amino compound

nizatidine
type: Concept
broader: tertiary amino compound

2-(2,3-dihydroindol-1-yl)-N-(phenylmethyl)-4-quinazolinamine
type: Concept
broader: tertiary amino compound

1-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
type: Concept
broader: tertiary amino compound

dihydro-beta-erythroidine
type: Concept
broader: tertiary amino compound

1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
type: Concept
broader: tertiary amino compound

3-O-acetylpapaveroxine
type: Concept
broader: tertiary amino compound

cocaine
type: Concept
broader: tertiary amino compound

thenalidine
type: Concept
broader: tertiary amino compound

psilocybin
type: Concept
broader: tertiary amino compound

voachalotine
type: Concept
broader: tertiary amino compound

monodansylcadaverine
type: Concept
broader: tertiary amino compound

(-)-noscapine hemiacetal
type: Concept
broader: tertiary amino compound

mesaconine
type: Concept
broader: tertiary amino compound

allocryptopine
type: Concept
broader: tertiary amino compound

alvocidib
type: Concept
broader: tertiary amino compound

4-(1,3-benzothiazol-2-yl)-5-[4-(N-methylanilino)-3-nitrophenyl]-4-pentenoic acid
type: Concept
broader: tertiary amino compound

PI-103
type: Concept
broader: tertiary amino compound

(4aS,10bR)-noroxomaritidine
type: Concept
broader: tertiary amino compound

2-[[4-(4-chloroanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol
type: Concept
broader: tertiary amino compound

(2R,3R)-10-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

AZD-8055
type: Concept
broader: tertiary amino compound

1-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

(-)-voacangine
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

midafotel
type: Concept
broader: tertiary amino compound

N,N-dimethyl-3-phenyl-3-(2-pyridinyl)-1-propanamine
type: Concept
broader: tertiary amino compound

2,6-dimethyl-4-tridecylmorpholine
type: Concept
broader: tertiary amino compound

momelotinib
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
type: Concept
broader: tertiary amino compound

aporphine
type: Concept
broader: tertiary amino compound

LRRK2-IN-1
type: Concept
broader: tertiary amino compound

benzatropine
type: Concept
broader: tertiary amino compound

(-)-vincadifformine
type: Concept
broader: tertiary amino compound

(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
type: Concept
broader: tertiary amino compound

4-(6-ethoxypyrazolo[1,5-b]pyridazin-3-yl)-N-[3-(morpholin-4-yl)phenyl]pyrimidin-2-amine
type: Concept
broader: tertiary amino compound

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

1-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

4-(4-morpholinyl)-N-phenyl-6-(1-pyrrolidinyl)-1,3,5-triazin-2-amine
type: Concept
broader: tertiary amino compound

N-{2-[(4-benzylpiperidin-1-yl)methyl]benzimidazol-5-yl}methanesulfonamide
type: Concept
broader: tertiary amino compound

N,N-dipropyl-2-(pyrrolidin-1-yl)quinazolin-4-amine
type: Concept
broader: tertiary amino compound

afimoxifene
type: Concept
broader: tertiary amino compound

N-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methylmethanesulfonamide
type: Concept
broader: tertiary amino compound

N-oxyethylpiperidine
type: Concept
broader: tertiary amino compound

carbinoxamine
type: Concept
broader: tertiary amino compound

sibutramine
type: Concept
broader: tertiary amino compound

NTA
type: Concept
broader: tertiary amino compound

xestospongin C
type: Concept
broader: tertiary amino compound

N,N-dimethylsphingosine
type: Concept
broader: tertiary amino compound

Cyprofuram
type: Concept
broader: tertiary amino compound

(2R,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
type: Concept
broader: tertiary amino compound

3-(2-methylpiperidin-1-yl)propyl 3,4-dichlorobenzoate
type: Concept
broader: tertiary amino compound

benzoylhypaconine
type: Concept
broader: tertiary amino compound

selexipag
type: Concept
broader: tertiary amino compound

trimipramine
type: Concept
broader: tertiary amino compound

prothiocarb
type: Concept
broader: tertiary amino compound

N-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
type: Concept
broader: tertiary amino compound

dofetilide
type: Concept
broader: tertiary amino compound

(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

naxagolide
type: Concept
broader: tertiary amino compound

1-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea
type: Concept
broader: tertiary amino compound

spiramycin I
type: Concept
broader: tertiary amino compound

3-Hydroxynevirapine
type: Concept
broader: tertiary amino compound

tandutinib
type: Concept
broader: tertiary amino compound

Dimethylaminopropyl Methacrylamide
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,1-dimethyl-4-imidazolesulfonamide
type: Concept
broader: tertiary amino compound

(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

mycophenolate mofetil
type: Concept
broader: tertiary amino compound

PF-956980
type: Concept
broader: tertiary amino compound

senbusine A
type: Concept
broader: tertiary amino compound

osimertinib
type: Concept
broader: tertiary amino compound

PD173074
type: Concept
broader: tertiary amino compound

dipyridamole
type: Concept
broader: tertiary amino compound

auramine O free base
type: Concept
broader: tertiary amino compound

2-(Dimethylamino)acetonitrile
type: Concept
broader: tertiary amino compound

(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

ranitidine
type: Concept
broader: tertiary amino compound

nelfinavir
type: Concept
broader: tertiary amino compound

N-{5-[2-{4-[2-(dimethylamino)ethoxy]phenyl}-4-(pyridin-4-yl)-1H-imidazol-5-yl]-2,3-dihydro-1H-inden-1-ylidene}hydroxylamine
type: Concept
broader: tertiary amino compound

tenovin-6
type: Concept
broader: tertiary amino compound

flavoxate
type: Concept
broader: tertiary amino compound

N,N-dibutyl-2-(pyridin-4-yl)quinazolin-4-amine
type: Concept
broader: tertiary amino compound

N-nonyldeoxynojirimycin
type: Concept
broader: tertiary amino compound

N-[[4-(diethylamino)phenyl]methylideneamino]carbamic acid tert-butyl ester
type: Concept
broader: tertiary amino compound

(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

rauvomitine
type: Concept
broader: tertiary amino compound

spiroxamine
type: Concept
broader: tertiary amino compound

7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
type: Concept
broader: tertiary amino compound

ethylisopropylamiloride
type: Concept
broader: tertiary amino compound

pirimicarb
type: Concept
broader: tertiary amino compound

N-[[(2R,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
type: Concept
broader: tertiary amino compound

LLNL-02
type: Concept
broader: tertiary amino compound

ivabradine
type: Concept
broader: tertiary amino compound

(S)-corytuberine
type: Concept
broader: tertiary amino compound

aminophenazone
type: Concept
broader: tertiary amino compound

4-(hydroxylamino)-N,N-dimethylaniline
type: Concept
broader: tertiary amino compound

DPI2
type: Concept
broader: tertiary amino compound

4-[5-(Difluoromethyl)-2-pyridinyl]morpholine
type: Concept
broader: tertiary amino compound

5-(5-chloro-1H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine
type: Concept
broader: tertiary amino compound

cyclopentolate
type: Concept
broader: tertiary amino compound

5-methoxy-N,N-dimethyltryptamine
type: Concept
broader: tertiary amino compound

1-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea
type: Concept
broader: tertiary amino compound

zotepine
type: Concept
broader: tertiary amino compound

(3R)-1,2-didehydro-3-hydroxy-2,3-dihydrotabersonine
type: Concept
broader: tertiary amino compound

levacetylmethadol
type: Concept
broader: tertiary amino compound

N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol
type: Concept
broader: tertiary amino compound

tilorone
type: Concept
broader: tertiary amino compound

N-(2-[(2-aminoethyl)(methyl)amino]-5-{[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino}phenyl)acetamide
type: Concept
broader: tertiary amino compound

sapitinib
type: Concept
broader: tertiary amino compound

10-hydroxycoronaridine
type: Concept
broader: tertiary amino compound

1-[[4-(dimethylamino)phenyl]methylideneamino]-3-(3-methoxypropyl)thiourea
type: Concept
broader: tertiary amino compound

3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine
type: Concept
broader: tertiary amino compound

LSM-10523
type: Concept
broader: tertiary amino compound

MLI-2
type: Concept
broader: tertiary amino compound

N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol
type: Concept
broader: tertiary amino compound

1-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
type: Concept
broader: tertiary amino compound

2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
type: Concept
broader: tertiary amino compound

N-{2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethyl}-N-propylpropan-1-amine hydrochloride
type: Concept
broader: tertiary amino compound

1-[[(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

benzydamine
type: Concept
broader: tertiary amino compound

2-(2,3-dihydro-1,4-benzoxazin-4-yl)-N-(phenylmethyl)-4-pyrimidinamine
type: Concept
broader: tertiary amino compound

BDA-366
type: Concept
broader: tertiary amino compound

(-)-noscapine
type: Concept
broader: tertiary amino compound

cinanserin
type: Concept
broader: tertiary amino compound

LSM-18554
type: Concept
broader: tertiary amino compound

propiomazine
type: Concept
broader: tertiary amino compound

tetracaine
type: Concept
broader: tertiary amino compound

(-)-minovincinine
type: Concept
broader: tertiary amino compound

retuline
type: Concept
broader: tertiary amino compound

(S)-nandinine
type: Concept
broader: tertiary amino compound

1-[[(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

buzepide
type: Concept
broader: tertiary amino compound

diphenhydramine
type: Concept
broader: tertiary amino compound

2-dimethylaminoethyl chloride
type: Concept
broader: tertiary amino compound

novacine
type: Concept
broader: tertiary amino compound

N-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
type: Concept
broader: tertiary amino compound

(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

KN-93
type: Concept
broader: tertiary amino compound

acepromazine
type: Concept
broader: tertiary amino compound

cortistatins
type: Concept
broader: tertiary amino compound

triflusulfuron-methyl
type: Concept
broader: tertiary amino compound

tamoxifen
type: Concept
broader: tertiary amino compound

desacetyldoronine
type: Concept
broader: tertiary amino compound

(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
type: Concept
broader: tertiary amino compound

lissoclibadin 1
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

disopyramide
type: Concept
broader: tertiary amino compound

cassaidine
type: Concept
broader: tertiary amino compound

16-methoxytabersonine
type: Concept
broader: tertiary amino compound

3-allyl-2-[2-(diethylamino)ethoxy]benzaldehyde
type: Concept
broader: tertiary amino compound

methiothepin
type: Concept
broader: tertiary amino compound

oxyacanthine
type: Concept
broader: tertiary amino compound

S-2-(dimethylamino)ethyl thiosulfate
type: Concept
broader: tertiary amino compound

flurazepam
type: Concept
broader: tertiary amino compound

GANT61
type: Concept
broader: tertiary amino compound

5-chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole
type: Concept
broader: tertiary amino compound

oxybuprocaine
type: Concept
broader: tertiary amino compound

N-(phosphonomethyl)iminodiacetic acid
type: Concept
broader: tertiary amino compound

1-[[(2R,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

akuammicine
type: Concept
broader: tertiary amino compound

vanoxerine
type: Concept
broader: tertiary amino compound

2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]phenol
type: Concept
broader: tertiary amino compound

1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-N-[4-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl]-1,4-dihydroquinoline-3-carboxamide
type: Concept
broader: tertiary amino compound

N-[1-[4-(4-bromophenyl)-2-thiazolyl]-4-piperidinyl]carbamic acid tert-butyl ester
type: Concept
broader: tertiary amino compound

iloperidone
type: Concept
broader: tertiary amino compound

N-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methylmethanesulfonamide
type: Concept
broader: tertiary amino compound

8-OH-DPAT
type: Concept
broader: tertiary amino compound

copanlisib
type: Concept
broader: tertiary amino compound

Ro 48-8071
type: Concept
broader: tertiary amino compound

5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate
type: Concept
broader: tertiary amino compound

clofedanol
type: Concept
broader: tertiary amino compound

1-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
type: Concept
broader: tertiary amino compound

sonidegib
type: Concept
broader: tertiary amino compound

martefragin A
type: Concept
broader: tertiary amino compound

N4,N4-dimethyl-N1-(4-nitro-1,1-dioxo-2,5-dihydrothiophen-3-yl)benzene-1,4-diamine
type: Concept
broader: tertiary amino compound

Src Inhibitor-5
type: Concept
broader: tertiary amino compound

2-[[4-(4-methylanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol
type: Concept
broader: tertiary amino compound

(2,6-diamino-4-piperidin-1-ylpyrimidin-1-ium-1-yl) hydrogen sulfate
type: Concept
broader: tertiary amino compound

O-desmethylvenlafaxine
type: Concept
broader: tertiary amino compound

[[4-(dimethylamino)phenyl]-(2-methylpropoxy)phosphoryl]-(2-fluorophenyl)methanol
type: Concept
broader: tertiary amino compound

hoerhammericine
type: Concept
broader: tertiary amino compound

trimethobenzamide
type: Concept
broader: tertiary amino compound

crenolanib
type: Concept
broader: tertiary amino compound

4-(dimethylamino)benzaldehyde
type: Concept
broader: tertiary amino compound

(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

josamycin
type: Concept
broader: tertiary amino compound

N-[[(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide
type: Concept
broader: tertiary amino compound

4-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol
type: Concept
broader: tertiary amino compound

pethidine
type: Concept
broader: tertiary amino compound

2-[4-[[4-(dimethylamino)phenyl]methylidene]-5-oxo-1-phenyl-3-pyrazolyl]acetic acid ethyl ester
type: Concept
broader: tertiary amino compound

1-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea
type: Concept
broader: tertiary amino compound

benfluralin
type: Concept
broader: tertiary amino compound

dacomitinib
type: Concept
broader: tertiary amino compound

chlorphenamine
type: Concept
broader: tertiary amino compound

3-cyclohexyl-1-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
type: Concept
broader: tertiary amino compound

3-(3,8-dinitro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-1-propanamine
type: Concept
broader: tertiary amino compound

N-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
type: Concept
broader: tertiary amino compound

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

chlortetracycline
type: Concept
broader: tertiary amino compound

5,6-didehydrosparteine
type: Concept
broader: tertiary amino compound

3-[[5,5-dimethyl-3-(4-morpholinyl)-1-cyclohex-2-enylidene]amino]-N,N-dimethylaniline
type: Concept
broader: tertiary amino compound

AZD1080
type: Concept
broader: tertiary amino compound

4-Carboxynevirapine
type: Concept
broader: tertiary amino compound

Ku-0063794
type: Concept
broader: tertiary amino compound

8-PIP-cAMP
type: Concept
broader: tertiary amino compound

N-[1-(4-butylphenyl)ethylideneamino]-2-methyl-6-(4-morpholinyl)-4-pyrimidinamine
type: Concept
broader: tertiary amino compound

3-(4-chlorophenyl)-6-(1-pyrrolidinyl)-1,2,4,5-tetrazine
type: Concept
broader: tertiary amino compound

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one
type: Concept
broader: tertiary amino compound

tesevatinib
type: Concept
broader: tertiary amino compound

6-hydroxyprotopine
type: Concept
broader: tertiary amino compound

10-hydroxyicajine
type: Concept
broader: tertiary amino compound

komodoquinone A
type: Concept
broader: tertiary amino compound

vindoline
type: Concept
broader: tertiary amino compound

dimethirimol
type: Concept
broader: tertiary amino compound

N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N(2),N(2)-dimethylglycinamide
type: Concept
broader: tertiary amino compound

ergometrine
type: Concept
broader: tertiary amino compound

N-methylparoxetine
type: Concept
broader: tertiary amino compound

hispidospermidin
type: Concept
broader: tertiary amino compound

organic amino compound
type: Concept
narrower: tertiary amino compound